259 related articles for article (PubMed ID: 9436954)
1. Aminoglycosides are useful for severe respiratory tract infections.
Craig WA; Andes D
Semin Respir Infect; 1997 Dec; 12(4):271-7. PubMed ID: 9436954
[TBL] [Abstract][Full Text] [Related]
2. [Contribution of experimental models to the treatment of respiratory tract infections].
Chidiac C; Nelson S; Summer WR; Mouton Y
Pathol Biol (Paris); 1989 Jun; 37(6):754-8. PubMed ID: 2780114
[TBL] [Abstract][Full Text] [Related]
3. The emergence of resistance to beta-lactam antibiotics during treatment of Pseudomonas aeruginosa lower respiratory tract infections: is combination therapy the solution?
Nichols L; Maki DG
Chemioterapia; 1985 Feb; 4(1):102-9. PubMed ID: 3986938
[TBL] [Abstract][Full Text] [Related]
4. Effect of aminoglycoside and beta-lactam combination therapy versus beta-lactam monotherapy on the emergence of antimicrobial resistance: a meta-analysis of randomized, controlled trials.
Bliziotis IA; Samonis G; Vardakas KZ; Chrysanthopoulou S; Falagas ME
Clin Infect Dis; 2005 Jul; 41(2):149-58. PubMed ID: 15983909
[TBL] [Abstract][Full Text] [Related]
5. [Tobramycin--clinical pharmacology and chemotherapy].
Periti P
J Chemother; 1996 Jan; 8 Suppl 1():3-30. PubMed ID: 8948764
[TBL] [Abstract][Full Text] [Related]
6. Aminoglycosides versus beta-lactams in gram-negative pneumonia.
Collins T; Gerding DN
Semin Respir Infect; 1991 Sep; 6(3):136-46. PubMed ID: 1754734
[TBL] [Abstract][Full Text] [Related]
7. Aminoglycoside drugs in clinical practice: an evidence-based approach.
Leibovici L; Vidal L; Paul M
J Antimicrob Chemother; 2009 Feb; 63(2):246-51. PubMed ID: 19022778
[TBL] [Abstract][Full Text] [Related]
8. [Treatment of severe infections: should one always administer an aminoglycoside?].
Cometta A; Baumgartner JD
Schweiz Med Wochenschr Suppl; 1996; 76():28S-33S. PubMed ID: 8677416
[TBL] [Abstract][Full Text] [Related]
9. Extended-interval once-daily dosing of aminoglycosides in adult and pediatric patients with cystic fibrosis.
Prescott WA; Nagel JL
Pharmacotherapy; 2010 Jan; 30(1):95-108. PubMed ID: 20030477
[TBL] [Abstract][Full Text] [Related]
10. In nosocomial pneumonia, optimizing antibiotics other than aminoglycosides is a more important determinant of successful clinical outcome, and a better means of avoiding resistance.
Schentag JJ; Birmingham MC; Paladino JA; Carr JR; Hyatt JM; Forrest A; Zimmer GS; Adelman MH; Cumbo TJ
Semin Respir Infect; 1997 Dec; 12(4):278-93. PubMed ID: 9436955
[TBL] [Abstract][Full Text] [Related]
11. Single versus combined antibiotic therapy for gram-negative infections.
Klibanov OM; Raasch RH; Rublein JC
Ann Pharmacother; 2004 Feb; 38(2):332-7. PubMed ID: 14742774
[TBL] [Abstract][Full Text] [Related]
12. Human pharmacodynamics of beta-lactams, aminoglycosides and their combination.
Drusano GL
Scand J Infect Dis Suppl; 1990; 74():235-48. PubMed ID: 2097712
[TBL] [Abstract][Full Text] [Related]
13. Effects of an alternative cefepime dosing strategy in pulmonary and bloodstream infections caused by Enterobacter spp, Citrobacter freundii, and Pseudomonas aeruginosa: a single-center, open-label, prospective, observational study.
Deal EN; Micek ST; Reichley RM; Ritchie DJ
Clin Ther; 2009 Feb; 31(2):299-310. PubMed ID: 19302902
[TBL] [Abstract][Full Text] [Related]
14. Aminoglycoside/beta-lactam combinations in clinical practice.
Leibovici L; Paul M
J Antimicrob Chemother; 2007 Nov; 60(5):911-2. PubMed ID: 17890282
[TBL] [Abstract][Full Text] [Related]
15. Antimicrobials in cystic fibrosis: emergence of resistance and implications for treatment.
Zabner R; Quinn JP
Semin Respir Infect; 1992 Sep; 7(3):210-7. PubMed ID: 1475544
[TBL] [Abstract][Full Text] [Related]
16. Antibiotic combinations for the empiric treatment of the febrile neutropenic patient.
Walsh TJ; Schimpff SC
Schweiz Med Wochenschr Suppl; 1983; 14():58-63. PubMed ID: 6361993
[TBL] [Abstract][Full Text] [Related]
17. Nosocomial infections due to multidrug-resistant Pseudomonas aeruginosa: epidemiology and treatment options.
Obritsch MD; Fish DN; MacLaren R; Jung R
Pharmacotherapy; 2005 Oct; 25(10):1353-64. PubMed ID: 16185180
[TBL] [Abstract][Full Text] [Related]
18. β-Lactam plus aminoglycoside or fluoroquinolone combination versus β-lactam monotherapy for Pseudomonas aeruginosa infections: a meta-analysis.
Vardakas KZ; Tansarli GS; Bliziotis IA; Falagas ME
Int J Antimicrob Agents; 2013 Apr; 41(4):301-10. PubMed ID: 23410791
[TBL] [Abstract][Full Text] [Related]
19. Therapeutic considerations in using combinations of newer beta-lactam antibiotics.
Barriere SL
Clin Pharm; 1986 Jan; 5(1):24-33. PubMed ID: 3512153
[TBL] [Abstract][Full Text] [Related]
20. Empiric antimicrobial therapy for febrile granulocytopenic cancer patients: lessons from four EORTC trials.
Klastersky J; Zinner SH; Calandra T; Gaya H; Glauser MP; Meunier F; Rossi M; Schimpff SC; Tattersall M; Viscoli C
Eur J Cancer Clin Oncol; 1988; 24 Suppl 1():S35-45. PubMed ID: 3280326
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
